High LDL causes: Difference between revisions
No edit summary |
|||
(29 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
High LDL can be primary or secondary to [[Saturated fat|diet high in saturated fat]], [[hypothyroidism]], [[nephrotic syndrome]], [[pregnancy]], [[obesity]], or medications such as [[amiodarone]], [[cyclosporine]], [[diuretics]], and [[glucocorticoids]].<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923 }} </ref> High LDL can also be caused by [[inherited]] diseases that affect the [[lipid metabolism]]. | |||
==Causes== | ==Causes== | ||
Line 9: | Line 10: | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. | ||
High LDL does not have any life-threatening cause. | |||
===Common Causes=== | ===Common Causes=== | ||
* [[Amiodarone]] | |||
* [[Anorexia]] | |||
* [[Biliary obstruction]] | |||
* [[Cyclosporine]] | |||
* [[Diuretics]] | |||
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref> | |||
* [[Glucocorticoids]] | |||
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi = | PMID = 15259529 }}</ref> | |||
* [[Hypothyroidism]] | |||
* [[Nephrotic syndrome]] | |||
* [[Obesity]] | |||
* [[Pregnancy]] | |||
* [[Weight gain]]<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923 }} </ref> | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 20: | Line 34: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical/Poisoning''' | | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| [[Diterpenoids]] | |bgcolor="Beige"| [[Terpenoid|Diterpenoids]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 32: | Line 46: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Amiodarone]], [[atazanavir]], [[azathioprine]], [[bexarotene]], [[Immunosuppressive drug#Drugs acting on immunophilins|calcineurin inhibitors]], [[chlortalidone]], [[corticosteroids]], [[cyclosporine]], [[Dapagliflozin]], [[Danazol]], [[desvenlafaxine]], [[diuretics]], [[Fish oil|fish oil supplements]], [[glucocorticoid]], [[immunosuppressive agents]], [[levonorgestrel]], [[lopinavir]], [[Medroxyprogesterone acetate]], [[mycophenolate]], [[nicotine]], [[norgestrel]], [[Norgestrel and Ethinyl estradiol]], [[prednisone]], [[progestin]], [[rapamycin]], [[rosiglitazone]], [[sirolimus]], [[thiazide]], [[tocilizumab]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 48: | Line 62: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Biliary obstruction]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Niemann-Pick disease|Acid sphingomyelinase deficiency]], [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]], [[familial combined hyperlipidemia]], [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]], [[familial hypercholesterolemia]], [[ | |bgcolor="Beige"| [[Niemann-Pick disease|Acid sphingomyelinase deficiency]], [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]], [[familial combined hyperlipidemia]], [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]], [[familial hypercholesterolemia]], [[Interleukin 28#Clinical Significance|IL 28B polymorphisms]], [[Niemann-Pick disease]], [[hypercholesterolemia|polygenic hypercholesterolemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 64: | Line 78: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[Gram negative | |bgcolor="Beige"| [[Gram negative bacteremia]], [[H. pylori]], [[small bowel bacterial overgrowth syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 76: | Line 90: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[Chenodeoxycholic acid]], [[high carbohydrate diet]], [[high saturated fat diet]], [[omega-3 polyunsaturated fatty acids]], [[polygenic hypercholesterolemia]], [[primary hyperlipoproteinemia]], [[primary hypolipoproteinemia | |bgcolor="Beige"| [[Chenodeoxycholic acid]], [[Carbohydrate#Nutrition|high carbohydrate diet]], [[Saturated fat|high saturated fat diet]], [[Omega-3 fatty acid|omega-3 polyunsaturated fatty acids]], [[Hypercholesterolemia|polygenic hypercholesterolemia]], [[primary hyperlipoproteinemia]], [[Hypolipoproteinemia pathophysiology#Primary Lipoprotein Disorders|primary hypolipoproteinemia]], [[selenium deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| [[Polycystic ovarian syndrome]] | |bgcolor="Beige"| [[Polycystic ovarian syndrome]], [[pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 108: | Line 122: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| [[Dysproteinemia]], [[lipopolysaccharides]], [[monoclonal | |bgcolor="Beige"| [[Dysproteinemia]], [[lipopolysaccharides]], [[monoclonal gammopathy]], [[paraproteinemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 124: | Line 138: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anorexia]], [[obesity]], [[weight gain]] | ||
|- | |- | ||
|} | |} | ||
Line 132: | Line 146: | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Niemann-Pick disease|Acid sphingomyelinase deficiency]] | *[[Niemann-Pick disease|Acid sphingomyelinase deficiency]] | ||
* [[Amiodarone]] | |||
*[[Androgens]] | *[[Androgens]] | ||
* [[Anorexia]] | |||
*[[Atazanavir]] | *[[Atazanavir]] | ||
*[[Familial hypercholesterolemia|Autosomal recessive hypercholesterolemia]] | *[[Familial hypercholesterolemia|Autosomal recessive hypercholesterolemia]] | ||
*[[Azathioprine]] | *[[Azathioprine]] | ||
*[[Bexarotene]] | *[[Bexarotene]] | ||
* [[Biliary obstruction]] | |||
*[[Immunosuppressive drug#Drugs acting on immunophilins|Calcineurin inhibitors]] | *[[Immunosuppressive drug#Drugs acting on immunophilins|Calcineurin inhibitors]] | ||
*[[Chenodeoxycholic acid]] | *[[Chenodeoxycholic acid]] | ||
Line 147: | Line 164: | ||
*[[Dehydroepiandrosterone]] | *[[Dehydroepiandrosterone]] | ||
*[[Desvenlafaxine]] | *[[Desvenlafaxine]] | ||
*[[Diterpenoids]] | *[[Terpenoid|Diterpenoids]] | ||
* [[Diuretics]] | |||
*[[Dysproteinemia]] | *[[Dysproteinemia]] | ||
*[[Familial combined hyperlipidemia]] | *[[Familial combined hyperlipidemia]] | ||
*[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]] | *[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Fish oil|Fish oil supplements]] | *[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref> | ||
*[[Gram negative | *[[Fish oil|Fish oil supplements]]<ref name="Pejic-">{{Cite journal | last1 = Pejic | first1 = RN. | last2 = Lee | first2 = DT. | title = Hypertriglyceridemia. | journal = J Am Board Fam Med | volume = 19 | issue = 3 | pages = 310-6 | month = | year = | doi = | PMID = 16672684 }}</ref> | ||
* [[Glucocorticoid]] | |||
*[[Gram negative bacteremia]] | |||
*[[Growth hormone deficiency]] | *[[Growth hormone deficiency]] | ||
*[[H. pylori]] | *[[H. pylori]] | ||
*[[High carbohydrate diet]] | *[[Carbohydrate#Nutrition|High carbohydrate diet]] | ||
*[[High saturated fat diet]] | *[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi = | PMID = 15259529 }}</ref> | ||
*[[Hypercortisolism]] | *[[Hypercortisolism]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[IL 28B polymorphisms]] | *[[Interleukin 28#Clinical Significance|IL 28B polymorphisms]] | ||
*[[Immunosuppressive agents]] | *[[Immunosuppressive agents]] | ||
*[[LDL receptor deficiency]] | *[[LDL receptor deficiency]] | ||
Line 168: | Line 186: | ||
*[[Lipopolysaccharides]] | *[[Lipopolysaccharides]] | ||
*[[Lopinavir]] | *[[Lopinavir]] | ||
*[[Monoclonal | *[[Monoclonal gammopathy]] | ||
*[[Mycophenolate]] | *[[Mycophenolate]] | ||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]]<ref name="Kronenberg-2005">{{Cite journal | last1 = Kronenberg | first1 = F. | title = Dyslipidemia and nephrotic syndrome: recent advances. | journal = J Ren Nutr | volume = 15 | issue = 2 | pages = 195-203 | month = Apr | year = 2005 | doi = | PMID = 15827892 }}</ref> | ||
*[[Nicotine]] | *[[Nicotine]] | ||
*[[Niemann- | *[[Niemann-Pick disease]] | ||
*[[Norgestrel]] | *[[Norgestrel]] | ||
*[[Norgestrel and Ethinyl estradiol]] | |||
* [[Obesity]] | |||
*[[Xanthomatous biliary cirrhosis|Obstructive liver disease]] | |||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[ | *[[Omega-3 fatty acid|Omega-3 polyunsaturated fatty acids]] | ||
*[[Pancreatitis]] | *[[Pancreatitis]] | ||
*[[Paraproteinemia]] | *[[Paraproteinemia]] | ||
*[[Polycystic ovarian syndrome]] | *[[Polycystic ovarian syndrome]] | ||
*[[Polygenic hypercholesterolemia]] | * [[Pregnancy]] | ||
*[[Hypercholesterolemia|Polygenic hypercholesterolemia]] | |||
*[[Prednisone]] | *[[Prednisone]] | ||
*[[Primary biliary cirrhosis]] | *[[Primary biliary cirrhosis]] | ||
*[[Primary hyperlipoproteinemia]] | *[[Primary hyperlipoproteinemia]] | ||
*[[Primary hypolipoproteinemia | *[[Hypolipoproteinemia pathophysiology#Primary Lipoprotein Disorders|Primary hypolipoproteinemia]] | ||
*[[Progestagens]] | *[[Progestagens]] | ||
*[[Progestin]] | *[[Progestin]] | ||
Line 196: | Line 217: | ||
*[[Thiazide]] | *[[Thiazide]] | ||
*[[Tocilizumab]] | *[[Tocilizumab]] | ||
* [[Weight gain]] | |||
{{col-end}} | {{col-end}} | ||
Latest revision as of 21:44, 16 January 2015
Low Density Lipoprotein Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
High LDL causes On the Web |
American Roentgen Ray Society Images of High LDL causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]; Vendhan Ramanujam M.B.B.S [4]
Overview
High LDL can be primary or secondary to diet high in saturated fat, hypothyroidism, nephrotic syndrome, pregnancy, obesity, or medications such as amiodarone, cyclosporine, diuretics, and glucocorticoids.[1] High LDL can also be caused by inherited diseases that affect the lipid metabolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
High LDL does not have any life-threatening cause.
Common Causes
- Amiodarone
- Anorexia
- Biliary obstruction
- Cyclosporine
- Diuretics
- Familial hypercholesterolemia[2]
- Glucocorticoids
- High saturated fat diet[3]
- Hypothyroidism
- Nephrotic syndrome
- Obesity
- Pregnancy
- Weight gain[1]
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.0 1.1 Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH; et al. (2014). "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 63 (25 Pt B): 2889–934. doi:10.1016/j.jacc.2013.11.002. PMID 24239923.
- ↑ 2.0 2.1 Durrington, P. (2003). "Dyslipidaemia". Lancet. 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Covington, MB. (2004). "Omega-3 fatty acids". Am Fam Physician. 70 (1): 133–40. PMID 15259529. Unknown parameter
|month=
ignored (help) - ↑ Pejic, RN.; Lee, DT. "Hypertriglyceridemia". J Am Board Fam Med. 19 (3): 310–6. PMID 16672684.
- ↑ Kronenberg, F. (2005). "Dyslipidemia and nephrotic syndrome: recent advances". J Ren Nutr. 15 (2): 195–203. PMID 15827892. Unknown parameter
|month=
ignored (help)